The clinic is working with the HFEA to plan for Brexit. These plans are updated as new information comes to light.
Please also find below link to NHSGGC Patient information related to Brexit.
Technology and Innovation
GRI ACS is looking forward to introducing further new innovative equipment into the ACS laboratories in July 2017.
Additional investment from NHSGGC and the Scottish Government continues to enable the ACS laboratories to remain at the forefront of new technology, ensuring that only state of the art equipment is used for patient treatment.
To enable introduction of this new equipment, we have planned a routine laboratory closure for three weeks between Wednesday 5th – Friday 21st July to allow the new equipment to be installed and tested. Existing equipment will also undertake mandatory annually servicing during this essential shutdown period.
We look forward to continuing to further improve the service we provide.
Patient Experience Survey Report
In May 2017, we invited 70 patients approaching the end of their fertility treatment to participate in an experience survey to evaluate the standard of service they received during their treatment with us.
We had a 100% response rate with 94.2% of respondents reporting that they’d had a positive experience during their treatment at Glasgow Royal Infirmary ACS. Whilst this overwhelmingly positive response is very encouraging, we are constantly striving to make further improvements to the service we provide, and therefore all feedback has been noted to allow us to develop our service further.
Please take a moment to look at the ‘Patient Feedback’ display in the ACS waiting room to see areas of your treatment where we aim to deliver further improvement and some positive feedback from patients that have already received treatment with us.
Poster Winner 2017
The ACS is proud to announce that one of our Embryologists [Catherine Beaton] won the Association of Clinical Embryologists (ACE) Pre-registrant Poster prize at the Fertility 2017 conference held in Edinburgh in January. The poster was entitled “Pregnancy outcomes following fresh or vitrified embryo transfer of non-top quality embryos. Should we change what we freeze?”
The prize is paid registration to the Fertility 2018 conference which will be held in Liverpool.
Well done Cathy! Another proud moment for the ACS scientific team.
New consultant gynaecologist
The ACS is delighted to announce the appointment of our new consultant gynaecologist, Claire Banks. Claire trained at Glasgow University and worked as a consultant within Clyde. Claire will start her post here at the ACS in January 2017.
Waiting list targets
The ACS is pleased to inform couples who are being referred from their GP that the current average waiting time from GP referral to the first ART clinic appointment at the ACS is 6-7 months.
The ACS is proud to announce that four poster abstracts, submitted by the scientific staff, have successfully been accepted for the Fertility 2017 conference, to be held in Edinburgh in January 2017.
Counselling survey results
In July/August 2016 the ACS invited patients attending the counselling service to participate in a satisfaction survey. The response was overwhelmingly positive, with 100% of respondents reporting that they’d use the service again and 100% reporting that they’d recommend to others to use the service. Our counsellor Isobel O’Neill received extremely positive feedback, and she is now joined by our second counsellor Alison Elliot. In respect of this, waiting times for counselling appointments are now down to approximately two weeks.
Patient survey results
In June 2016, the ACS invited patients receiving embryo transfer to participate in a satisfaction survey. The response was good with over 90% of respondents reporting that they’d had a positive experience at the suite. Whilst the response was so encouraging, we are constantly striving for improvement and all comments have been noted for ongoing service development.
Poster winner 2016
The ACS is proud to announce that one of our Embryologists [George Hughes] won the Pre-registrant Poster prize at the Association of Clinical Embryologists (ACE) conference held in Newcastle in January 2016. The poster entitled ‘Volatile organic compounds in CE marked consumables in a clinical IVF laboratory’ explored the levels of volatile compounds given off when opening laboratory plasticware and the implications for use in an assisted conception unit.] The prize was a paid registration to the Fertility 2017 conference, held in Edinburgh in January 2017.
Facing the Future Together, Chairman’s Award winners 2015
In late 2015, a series of awards were made to departments across NHS Greater Glasgow and Clyde, celebrating the dedication and success of the hard work of the staff. The ACS staff members were honoured as the winners in the ‘Our People’ category for the Acute Services, Women and Children’s. This award was made for teamwork and notably the successful achievement of the new waiting times targets throughout the relocation of clinical services back to the refurbished Royal Infirmary site.
Press Release October 2015
The refurbished Assisted Conception Service (ACS) is achieving its highest ever success rates since moving back to Glasgow Royal Infirmary a year ago.
The state-of-the-art facility treats patients from across the West of Scotland and beyond and is seeing a 54% positive pregnancy test rate for all fresh embryo transfers - the highest rate unit has ever recorded.
The service now offers seven day access which means all patients are offered individualised treatment which meets their own clinical need.
Patients also now benefit from the use of time-lapse technology which allows continuous assessment of their IVF embryos, whilst enabling them to remain undisturbed in optimal conditions in the incubator. This has the advantage of allowing embryos to develop in culture for longer and thereby improves the ability to select the best embryo for transfer with the highest chance of achieving a pregnancy.
Dr Helen Lyall, Lead Consultant, said: “I am delighted that the unit is seeing such an increase in success rates and we hope this continues to grow.
“One of the main benefits of the newly refurbished unit is that all functions are now located within the one area. Prior to the refurbishment, services were spread across the Glasgow Royal Infirmary site.
“The investment in the facility and state of the art equipment has increased capacity at this new facility and has also enabled us to treat patients within the 12 months target.”
Dr Helen Lyall and Isabel Traynor, Senior Charge Nurse, have made a massive contribution to the National Infertility Group established by Scottish Government Ministers in 2010.
Their input, along with that of the wider team of doctors, nurses, embryologists and administrative staff has been instrumental in achieving equity of access across Scotland for patients requiring assisted conception treatment.
Dr Helen Lyall (Consultant) and Isabel Traynor (Senior Charge Nurse) from the Assisted Conception Unit were invited to attend the Queen's Garden Party at the Palace of Holyrood on Wednesday 1st July. This was in recognition of the work both have done for the Scottish Government as part of the National Infertility Group.
This work has been instrumental in achieving equity of access across Scotland for patients needing assisted conception treatment. This followed an exciting year for the assisted conception services in Glasgow with a new 'state of the art' facility in Glasgow Royal Infirmary, opened by the Minister for Health Shona Robison in February 2015.
The ACS laboratory had 2 additional EmbryoScopes installed in July which now means we have a total of 6 in place. This is the highest number of EmbryoScopes in any clinic in Scotland, reflecting the high number of patients we treat. We can now ensure that all patients have their embryos incubated in time-lapsed imaging systems. This helps us to select the best embryo to transfer and thereby give the highest chance of pregnancy.
We have also had approval for a new laser system to continue our improvements to our Pre Genetic Diagnostic service whereby genetic diseases can be screened for to ensure non- affected embryos are replaced and children are born healthy.